Targeting the IL-17 Pathway in Inflammatory Disorders

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting th...

Full description

Saved in:
Bibliographic Details
Main Author Chu, Cong-Qiu (Author)
Corporate Author SpringerLink (Online service)
Format Electronic eBook
LanguageEnglish
Published Cham : Springer International Publishing : Imprint: Adis, 2017.
Subjects
Online AccessFull text
ISBN9783319280400
DOI10.1007/978-3-319-28040-0
Physical DescriptionXV, 102 p. 6 illus. in color. online resource.

Cover

LEADER 00000nam a22000005i 4500
001 101608
003 CZ-ZlUTB
005 20251008112036.0
006 m o d
007 cr nn 008mamaa
008 161128s2017 gw | s |||| 0|eng d
020 |a 9783319280400 
024 7 |a 10.1007/978-3-319-28040-0  |2 doi 
100 1 |a Chu, Cong-Qiu.  |e author. 
245 1 0 |a Targeting the IL-17 Pathway in Inflammatory Disorders /  |c by Cong-Qiu Chu. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2017. 
300 |a XV, 102 p. 6 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
505 0 |a Introduction -- Overview of IL-17 family.-Il-17 in host defense -- Th17 cells: differentiation and regulation -- The role of the IL-17/Th17 pathway in the pathogenesis of autoimmune inflammatory diseases -- Therapeutic applications: strategies and molecules targeting the IL-17/Th17 pathway -- Concluding remarks. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals. 
650 0 |a Medicine. 
650 0 |a Dermatology. 
650 0 |a Public health. 
650 0 |a Rheumatology. 
650 0 |a Primary care (Medicine). 
650 0 |a Pharmacotherapy. 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 9 |a electronic books  |2 eczenas 
710 2 |a SpringerLink (Online service) 
776 0 8 |i Printed edition:  |z 9783319280394 
856 4 0 |u https://proxy.k.utb.cz/login?url=http://dx.doi.org/10.1007/978-3-319-28040-0 
992 |c NTK-SpringerMED 
999 |c 101608  |d 101608 
993 |x NEPOSILAT  |y EIZ